Copa Holdings enters June with a curious split: the stock pulled back nearly 4% on the week, yet the short-selling community has spent the last month unwinding positions, and the Street just lifted its targets again. That divergence — price softening while bearish conviction fades — is the defining tension heading into the summer.
The clearest short-side story is one of retreat. Short interest as a percentage of the free float has fallen to 5.1%, down 11% over the past week and roughly 9% over the past month. To put that in context, it peaked in mid-May near 5.9% and has been declining consistently since. The borrow market confirms shorts are not leaning harder on the name — the lending pool is extraordinarily loose, with availability at roughly 2,480% of estimated short interest. That means there are nearly 25 times as many shares available to borrow as there are shares currently borrowed. Even with cost to borrow ticking up 27% on the week to 0.58%, the absolute level remains negligible in the context of the overall equity return profile. The ORTEX short score has also declined, moving from around 43 in late May to 39.9 now — a direction of travel that signals diminishing short-side conviction rather than any building squeeze pressure.
Options positioning has turned more cautious, but not dramatically so. The put/call ratio is running at 1.70, modestly above its 20-day average of 1.53 at a z-score of 0.68 — elevated compared to where it was in late April, but nowhere near the year's defensive extreme of 3.17. The shift higher in the PCR since mid-May tracks neatly with the stock's 4% pullback this week from the month's highs, suggesting some incremental hedging activity rather than outright directional bearishness. The overall positioning picture — shorts falling, borrows loose, options mildly elevated — reads more like profit-taking after a strong month than a structural re-rating.
JP Morgan lifted its target on CPA to $170 from $165 on June 3, maintaining its Overweight rating. That's the most recent move, but it sits inside a broader trend of upward revisions. UBS raised its target to $195 from $185 in late May. Evercore ISI lifted to $175 from $160 immediately after the May earnings print. Goldman Sachs followed in the same window, moving to $156 from $138. The consensus mean sits at $165 against a current price of $136.83, implying roughly 21% upside to the Street's central case. What's notable is the direction of travel: every target move since mid-May has been upward, reversing a wave of cuts seen in March when carriers generally faced weaker demand forecasts. Goldman had in fact upgraded to Buy back in April while cutting its target — a call that now looks prescient given the subsequent rally.
The earnings reaction history adds important context. Copa's May 13–14 results generated a one-day move of nearly 17% and a five-day move of the same magnitude. The prior print in early May 2026 produced an 8% single-day gain. The stock has a consistent history of large positive reactions to quarterly results — the upcoming Q2 release is scheduled for August 5. The valuation remains notably cheap relative to that earnings track record: the PE is around 7.7x on the current snapshot data, EV/EBITDA near 5.0x, and EV/EBIT just above 7.4x. The factor score for EV/EBIT ranks in the 88th percentile of the universe, underlining just how inexpensive the airline trades on an enterprise basis. Meanwhile the 30-day EPS momentum factor scores at 87, consistent with the wave of post-earnings target upgrades.
Peer carriers offered mixed signals this week. UAL gained 2.7% on the week despite falling 2.6% on the day. AAL fell 6.2% on the week — the worst of the group — while LATAM dropped 3.4%. Copa's own 3.8% weekly decline put it toward the softer end of the peer set, though the month-to-date picture remains strongly positive at +17.7%. The key watch for the coming weeks is whether the pullback in the stock — running against a backdrop of retreating shorts, rising targets, and loose availability — settles as a natural consolidation after May's outsized earnings move, or whether the elevated options PCR signals something more prolonged ahead of the August earnings date.
See the live data behind this article on ORTEX.
Open CPA on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
